ABIRATERONE ACETATE 250 MG TAB
For 30 tablets
Pharmacies pay
$23.22 filed
30 × $0.77414 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$663.29 filed
30 × $22.10961 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
28.6× estimated
These two figures may not measure the same thing
At 28.6×, the Medicare figure is 20 or more times what pharmacies pay. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.
Part D averages every strength and form sold under “Abiraterone Acetate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$31.70 estimated
$23.22 + $3.48 (15%) + $5.00 fee per fill = $31.70
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ABIRATERONE ACETATE 250 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “abiraterone” and “abiraterone acetate”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.
FDA lists 18 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Mylan Pharmaceuticals Inc. and Major Pharmaceuticals.
FDA’s Established Pharmacologic Class for it is Cytochrome P450 17A1 Inhibitor.
The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 21 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $23.22 for 30 tablets (30 × $0.77414 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 18 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Dr. Reddys Laboratories Inc | 2 | $0.77414 per EA filed |
| NorthStar Rx LLC | 2 | $0.77414 per EA filed |
| Novadoz Pharmaceuticals LLC | 2 | $0.77414 per EA filed |
| American Health Packaging | 1 | $0.77414 per EA filed |
| Amneal Pharmaceuticals LLC | 1 | $0.77414 per EA filed |
| Amneal Pharmaceuticals NY LLC | 1 | $0.77414 per EA filed |
| Apotex Corp. | 1 | $0.77414 per EA filed |
| AvPAK | 1 | $0.77414 per EA filed |
| BluePoint Laboratories | 1 | $0.77414 per EA filed |
| CivicaScript, LLC | 1 | $0.77414 per EA filed |
| Florida Pharmaceutical Products, LLC. | 1 | $0.77414 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.77414 per EA filed |
| Hikma Pharmaceuticals USA Inc. | 1 | $0.77414 per EA filed |
| Major Pharmaceuticals | 1 | $0.77414 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.77414 per EA filed |
| Novugen Pharma (USA) LLC | 1 | $0.77414 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.77414 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.77414 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.77414 per EA filed |
All 23 NDCs, with labeler and price
- 00143-9597-21 · Hikma Pharmaceuticals USA Inc. · $0.77414 per EA · eff. 2026-09-23 filed
- 00378-6920-78 · Mylan Pharmaceuticals Inc. · $0.77414 per EA · eff. 2026-09-23 filed
- 00904-6948-04 · Major Pharmaceuticals · $0.77414 per EA · eff. 2026-09-23 filed
- 16714-0963-01 · NorthStar Rx LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 43598-0358-04 · Dr. Reddys Laboratories Inc · $0.77414 per EA · eff. 2026-09-23 filed
- 50268-0032-11 · not listed as a package in the FDA directory · $0.77414 per EA · eff. 2026-09-23 filed
- 50268-0032-12 · AvPAK · $0.77414 per EA · eff. 2026-09-23 filed
- 60219-1165-07 · Amneal Pharmaceuticals LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 60505-4327-01 · Apotex Corp. · $0.77414 per EA · eff. 2026-09-23 filed
- 60687-0790-11 · not listed as a package in the FDA directory · $0.77414 per EA · eff. 2026-09-23 filed
- 60687-0790-21 · American Health Packaging · $0.77414 per EA · eff. 2026-09-23 filed
- 64980-0418-12 · Rising Pharma Holdings, Inc. · $0.77414 per EA · eff. 2026-09-23 filed
- 68001-0489-07 · BluePoint Laboratories · $0.77414 per EA · eff. 2026-09-23 filed
- 68462-0135-08 · Glenmark Pharmaceuticals Inc., USA · $0.77414 per EA · eff. 2026-09-23 filed
- 69238-1165-07 · Amneal Pharmaceuticals NY LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 71921-0178-20 · Florida Pharmaceutical Products, LLC. · $0.77414 per EA · eff. 2026-09-23 filed
- 72205-0030-92 · Novadoz Pharmaceuticals LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 72205-0284-92 · Novadoz Pharmaceuticals LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 72603-0110-01 · NORTHSTAR RX LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 75907-0224-04 · Dr. Reddys Laboratories Inc · $0.77414 per EA · eff. 2026-09-23 filed
- 82009-0139-12 · Quallent Pharmaceuticals Health LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 82249-0010-12 · CivicaScript, LLC · $0.77414 per EA · eff. 2026-09-23 filed
- 82293-0001-10 · Novugen Pharma (USA) LLC · $0.77414 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share an FDA nonproprietary name with ABIRATERONE ACETATE 250 MG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ABIRATERONE ACETATE 250 MG TAB this page | $0.77414 per EA filed | $22.10961 per EA filed |
| ABIRATERONE ACETATE 500 MG TAB | $2.59443 per EA filed | $22.10961 per EA filed |
| ABIRTEGA 250 MG TABLET | $0.77414 per EA filed | $22.10961 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $663.29 for 30 tablets, at an average of $22.10961 per EA in 2024 (2024-01-01 to 2024-12-31) for “Abiraterone Acetate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 389,368 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
19 of the product’s 23 NDCs have this Medicare figure; the other 4 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ABIRATERONE ACETATE 250 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Abiraterone Acetate / Abiraterone Acetate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.